实用肝脏病杂志 ›› 2019, Vol. 22 ›› Issue (6): 924-927.doi: 10.3969/j.issn.1672-5069.2019.06.037

• 原发性胆汁性胆管炎 • 上一篇    下一篇

原发性胆汁性胆管炎患者胆囊病变临床分析

李琪, 曾阿娟, 孟雯, 张海英, 李雪梅   

  1. 100069 北京市 首都医科大学附属北京佑安医院消化中心(李琪,曾阿娟); 慢病管理中心(孟雯,李雪梅); 超声科(张海英)
  • 收稿日期:2019-01-16 出版日期:2019-11-13 发布日期:2019-11-13
  • 通讯作者: 李雪梅,E-mail: yayymbglzx@163.com
  • 作者简介:李琪,女,38岁,医学博士。主要从事慢性肝病的基础与临床研究。E-mail: lickey2006@126.com

Clinical analysis of cholecystopathy in patients with primary biliary cholangitis

Li Qi, Zeng Ajuan, Meng Wen, et al.   

  1. Chronic Disease Management Center,You’an Hospital Affiliated to Capital Medical University,Beijing 100069,P.R. ChinaCorrspondence:Li Xuemei,E-mail:yayymbglzx@163.com
  • Received:2019-01-16 Online:2019-11-13 Published:2019-11-13

摘要: 目的 分析总结原发性胆汁性胆管炎(PBC)患者胆囊病变的特点。方法 回顾性分析110例PBC患者超声检查胆囊病变情况。结果 83.6%PBC患者发现胆囊壁毛糙,42.7%有胆囊炎,40.0%有胆囊壁增厚,22.7%有胆囊结石,19.1%有胆囊息肉,18.2%有胆囊壁水肿;44例伴胆囊壁增厚的与66例不伴胆囊壁增厚的PBC患者白细胞计数分别为【(4.3±1.8)×109/L和(5.2±2.3)×109/L,P<0.05】,血红蛋白为【(96.4±25.8) g/L和(122.1±18.2) g/L,P<0.05】,血小板计数为【(122.3±101.7)×109/L和(178.2±81.8)×109/L,P<0.05】,总胆红素为【(71.1±81.1) μmol/L和(26.4±34.3) μmol/L,P<0.05】,白蛋白为【(31.2±6.1) g/L和(41.2±6.1) g/L,P<0.05】,胆碱酯酶为【(3247.8±2058.9) U/L和(6829.3±2698.9) U/L,P<0.05】,总胆固醇为【(3.6±1.4) mmol/L和(4.8±1.5) mmol/L,P<0.05】,门静脉内径为【(11.9±1.8) mm和(11.3±1.6) mm,P<0.05】;不伴胆囊壁增厚组腹水发生率为16.7%,显著低于伴胆囊壁增厚组的68.2%(P<0.05);前者胆囊炎占4.5%,显著低于后者的100.0%(P<0.05),前者无胆囊壁水肿,后者为45.5%(P<0.05),前者胆囊壁毛糙占100%,显著高于后者的59.1% (P<0.05),前者肝功能B/C级占19.7%,显著低于后者的68.2%(P<0.05)。结论 胆囊病变为PBC患者的常见表现,胆囊壁毛糙、胆囊炎和胆囊壁增厚为最常见的3种胆囊病变类型,应加强临床分析,及时进行针对性干预,从而改善患者预后。

关键词: 原发性胆汁性胆管炎, 胆囊病变, 胆囊壁增厚, 超声

Abstract: Objective To summarize the characteristics of cholecystopathy in patients with primary biliary cholangitis(PBC). Methods A total of 110 patients with PBC were enrolled in this study and their cholecystopathy was retrospectively analyzed. Results Out of 110 patients with PBC,83.6% had gallbladder wall roughness,42.7% had cholecystitis,40.0% had gallbladder wall thickening,22.7% had gallstone,19.1% had gallbladder polyp,and 18.2% had gallbladder wall edema;in 44 PBC patients with and 66 without gallbladder wall thickening,leukocyte counts were [(4.3±1.8)×109/L vs. (5.2±2.3)×109/L,P<0.05],hemoglobin was [(96.4±25.8) g/L vs. (122.1±18.2) g/L,P<0.05],platelet counts were [(122.3±101.7)×109/L vs.(178.2±81.8)×109/L,P<0.05],total serum bilirubin levels was [(71.1±81.1) μmol/L vs. (26.4±34.3) μmol/L,P<0.05],serum albumin level was [(31.2±6.1) g/L vs. (41.2±6.1) g/L,P<0.05],cholinesterase was [(3247.8±2058.9) U/L vs. (6829.3±2698.9) U/L,P<0.05],total cholesterol was [(3.6±1.4) mmol/L vs. (4.8±1.5) mmol/L,P<0.05],and inner diameters of portal vein were [(11.9±1.8) mm vs. (11.3±1.6)mm,P<0.05];the percentage of ascites in PBC patients without gall bladder wall thickening was 16.7%,significantly lower than 68.2% in PBC with gallbladder wall thickening(P<0.05);the percentage of cholecystitis in the former group was 4.5%,significantly lower than 100.0% in the latter (P<0.05);there was no patient with gallbladder wall edema in the former,while there was 45.5% with gallbladder wall edema in the latter(P<0.05);the percentage of gallbladder wall roughness in the former was 100.0%,significantly higher than 59.1% (P<0.05) in the latter;in the former group,19.7% patients were with liver function Child class B or C,much lower than 68.2% in the latter (P<0.05). Conclusion Cholecystopathy is a common manifestation in patients with PBC and gallbladder wall roughness,cholecystitis and gallbladder wall thickening are the most common types of cholecystopathy.

Key words: Primary biliary cholangitis, Cholecystopathy, Gallbladder wall thickening, Cholecystitis, Ultrasound